Day: March 9, 2026

us corporate news

Relmada Therapeutics Announces 76% 12-Month Complete Response Rate in Phase 2 NDV-01 Trial for High-Risk Non-Muscle Invasive Bladder Cancer

Minichart

March 9, 2026

Relmada Therapeutics Reports Promising 12-Month Phase 2 Data...

Continue Reading 0

us corporate news

3D Systems Corporation Reports 2025 Financial Results: Revenue, Gross Profit, and Segment Performance Analysis

Minichart

March 9, 2026

3D Systems Corporation Reports Q4 and Full Year 2025 Financi...

Continue Reading 0

us corporate news

enGene Holdings Inc. Announces Sales Agreement with Leerink Partners LLC for At-the-Market Offering of Common Shares

Minichart

March 9, 2026

Engene Holdings Inc. – Key Developments in Latest 8-K Filing...

Continue Reading 0

us corporate news

Kalaris Therapeutics TH103: Next-Generation Anti-VEGF for Retinal Diseases Shows Promising Phase 1a Results and Extended Durability 23578

Minichart

March 9, 2026

Kalaris Therapeutics Provides Comprehensive Pipeline Update ...

Continue Reading 0

us corporate news

Dianthus Therapeutics Reports 2025 Financial Results and Advancements in Claseprubart Phase 3 Trials for Autoimmune Diseases

Minichart

March 9, 2026

Dianthus Therapeutics, Inc. (DNTH) Q4 & FY2025 Earnings and ...

Continue Reading 0

us corporate news

Spruce Biosciences Reports 2025 Financial Results, Advances TA-ERT for MPS IIIB with FDA, and Secures $50M Growth Capital

Minichart

March 9, 2026

Spruce Biosciences 2025 Results & Corporate Update: Detailed...

Continue Reading 0

us corporate news

Abeona Therapeutics Announces Momentum in ZEVASKYN® Gene Therapy Launch for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Minichart

March 9, 2026

Abeona Therapeutics Provides Detailed Business Update on ZEV...

Continue Reading 0

us corporate news

Creative Media & Community Trust Corporation Reports Q4 2025 Results and Announces Balance Sheet, FFO Improvements

Minichart

March 9, 2026

Creative Media & Community Trust Corporation Reports Q4 2025...

Continue Reading 0

us corporate news

Korro Bio Raises $85 Million in Oversubscribed PIPE Financing to Advance RNA Editing Therapies and Extend Cash Runway into 2028

Minichart

March 9, 2026

Korro Bio Announces Oversubscribed \$85 Million Private Plac...

Continue Reading 0

us corporate news

FuelCell Energy Reports 61% Q1 2026 Revenue Growth, Expands Data Center Power Strategy and Strengthens Liquidity

Minichart

March 9, 2026

FuelCell Energy Reports Strong Q1 2026 Revenue Growth and Ad...

Continue Reading 0